Use of triplex structure DNA sequences for transferring nucleotide sequences

Details for Australian Patent Application No. 2003271326 (hide)

Owner Institut Pasteur

Inventors Zennou, Veronique; Firat, Huseyin; Charneau, Pierre

Agent Cullen & Co

Pub. Number AU-B-2003271326

Parent 34272

Filing date 23 December 2003

Wipo publication date 29 January 2004

Acceptance publication date 28 June 2007

International Classifications

C12N 15/86 (2006.01) Mutation or genetic engineering - Viral vectors

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C07K 14/16 (2006.01) Peptides having more than 20 amino acids

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 7/04 (2006.01) Viruses, e.g. bacteriophages - Inactivation or attenuation

C12N 15/87 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation

Event Publications

15 January 2004 Complete Application Filed

29 January 2004 Application Open to Public Inspection

  Published as AU-B-2003271326

28 June 2007 Application Accepted

  Published as AU-B-2003271326

25 October 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003271327-Semi-constrained ankle prosthesis with a front loading polymer bearing

2003271325-GLP-1 Analogues